Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methocarbamol and Orphenadrine for Acute Low Back Pain
NCT02665286Phase 4Completed
- Sponsor
- Montefiore Medical Center
- Start
- Mar 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in low back pain (LBP) comparing Placebo, Orphenadrine and Methocarbamol (3 arms). Primary endpoint: Roland Morris Disability Questionnaire at 1 week. Started Mar 2016; status: completed.
02
Drugs
methocarbamolorphenadrine
03
Conditions
low back pain (LBP)
Beyond the preview
Go deeper on NCT02665286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02665286.